Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access chronic spontaneous urticaria specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic spontaneous urticaria treatment provided free
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.
Sponsor: Celldex Therapeutics
Check if you qualify for this chronic spontaneous urticaria clinical trial in Scottsdale, AZ
If you're searching for chronic spontaneous urticaria treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.